Research & Development



  “陛下,不要拿奴婢們出氣,這沒有用。”   只有跳出紅塵,才能看清楚這個世界,從表像直指靈魂,你不能一直活在回憶跟痛苦中。2014春节彩票休市安排   剛剛被熱水浸泡過,懷化公主的臉上浮現出了一絲血色,抓著隋越的手低聲道︰“就吃一口!”2014世界杯足球彩票   宋喬弄不明白這師徒兩個到底怎麼了,見霍光一張臉板的緊緊的,就笑道︰“你害得何公公多挨了幾天的餓,這幾天可不要往後山跑了。何公公跟雲音兩個正商量怎麼扒你的皮呢。”   鎧甲鏗鏘,刀槍如林,戰旗飛揚,腳步如雷,他們將要用自己的腳步丈量長安到北海的遙遠空間。2014彩票的发展   夏侯靜笑了,起身來到夏侯蘭身邊,看著夏侯蘭的眼楮道︰“你覺得能逃脫老夫的掌控嗎?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo